We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+524.93%
AUM
$96.6B
AUM Growth
-$813M
Cap. Flow
-$2.51B
Cap. Flow %
-2.6%
Top 10 Hldgs %
13.1%
Holding
822
New
68
Increased
222
Reduced
455
Closed
69

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$743M
2
GILD icon
Gilead Sciences
GILD
+$513M
3
LH icon
Labcorp
LH
+$508M
4
CI icon
Cigna
CI
+$348M
5
EPAM icon
EPAM Systems
EPAM
+$304M

Sector Composition

Rank Sector Weight
1 Financials 20.9%
2 Technology 15.16%
3 Industrials 14.83%
4 Healthcare 12.72%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LW icon
226
Lamb Weston
LW
$7.39B
$85.5M 0.09%
2,042,216
-51,728
-2% -$3.04M
TNET icon
227
TriNet
TNET
$3.22B
$85.3M 0.09%
1,441,715
-19,180
-1% -$1.14M
ACN icon
228
Accenture
ACN
$109B
$83.6M 0.09%
311,611
-15,650
-5% -$3.98M
LRCX icon
229
Lam Research
LRCX
$422B
$81.8M 0.08%
476,275
-186,079
-28% -$28.9M
DD icon
230
DuPont de Nemours
DD
$19.5B
$78.2M 0.08%
648,494
-2,544,337
-80% -$286M
BGC icon
231
BGC Group
BGC
$5.2B
$77.9M 0.08%
8,751,971
+98,996
+1% +$892K
LAUR icon
232
Laureate Education
LAUR
$5.15B
$77.8M 0.08%
2,291,629
-202,196
-8% -$6.24M
KDP icon
233
Keurig Dr Pepper
KDP
$42.3B
$77.8M 0.08%
2,776,316
-141,291
-5% -$3.88M
MMS icon
234
Maximus
MMS
$2.94B
$76.8M 0.08%
880,539
-85,600
-9% -$7.32M
BIO icon
235
Bio-Rad Laboratories Class A
BIO
$9.66B
$75M 0.08%
+247,612
New +$77.3M
KBR icon
236
KBR
KBR
$4.81B
$74.1M 0.08%
1,830,360
+369,629
+25% +$15.8M
FLS icon
237
Flowserve
FLS
$10.3B
$72.6M 0.08%
1,046,076
-674,736
-39% -$43.4M
KLAC icon
238
KLA
KLAC
$274B
$71.7M 0.07%
588,990
-240,010
-29% -$28.2M
MRK icon
239
Merck
MRK
$334B
$70.4M 0.07%
668,722
-34,160
-5% -$3.21M
AGO icon
240
Assured Guaranty
AGO
$3.35B
$68.3M 0.07%
766,651
-24,530
-3% -$2.12M
MGNI icon
241
Magnite
MGNI
$3.53B
$66.6M 0.07%
4,108,893
-340,111
-8% -$5.65M
OMC icon
242
Omnicom Group
OMC
$24.2B
$66.5M 0.07%
823,907
-2,358,467
-74% -$180M
QCOM icon
243
Qualcomm
QCOM
$173B
$66.2M 0.07%
387,442
-17,419
-4% -$2.99M
BCO icon
244
Brink's
BCO
$4.72B
$65.7M 0.07%
559,013
-48,895
-8% -$5.59M
ASO icon
245
Academy Sports + Outdoors
ASO
$3.03B
$65.3M 0.07%
1,293,208
-8,933
-0.7% -$443K
SAIC icon
246
Saic
SAIC
$5.35B
$64.9M 0.07%
643,455
-32,591
-5% -$3.11M
GVA icon
247
Granite Construction
GVA
$5.41B
$62.8M 0.07%
537,939
-47,629
-8% -$5.12M
AGM icon
248
Federal Agricultural Mortgage
AGM
$2.51B
$60.2M 0.06%
345,551
+6,800
+2% +$1.14M
VYX icon
249
NCR Voyix
VYX
$1.17B
$58.9M 0.06%
5,747,857
-48,589
-0.8% -$528K
IWD icon
250
iShares Russell 1000 Value ETF
IWD
$84.3B
$58.4M 0.06%
273,930
+210,590
+332% +$43.5M

Similar funds

Boston Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Boston Partners held 822 positions worth $96.6B, down 0.83% from $97.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2025 filing shows 68 new, 222 increased, 455 reduced and 69 closed positions. Its largest new stake was Meta Platforms (Facebook): 1,113,139 shares worth $733M. The largest sale was Alphabet (Google) Class A, an estimated $837M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 1,113,139 shares worth $733M.
  • Boston Partners added most to Cigna in Q4 2025, an estimated $348M increase.
  • Boston Partners's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $837M.
  • Boston Partners fully exited Harley-Davidson in Q4 2025, selling an estimated $112M.
  • Boston Partners's ten largest holdings make up 13% of its $96.6B portfolio in Q4 2025.
  • Boston Partners opened 68 new positions and closed 69 in Q4 2025.
  • Boston Partners's portfolio value fell 0.83% quarter-over-quarter to $96.6B.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.